Barnett & Company’s Gilead Sciences GILD Stock Holding History

Barnett & Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-250	Closed	-$18K	–	159
2021 Q4	$18K	Hold	250	–	–	0.01%	166
2021 Q3	$17K	Hold	250	–	–	0.01%	156
2021 Q2	$17K	Hold	250	–	–	0.01%	184
2021 Q1	$16K	Hold	250	–	–	0.01%	229
2020 Q4	$14K	Hold	250	–	–	0.01%	232
2020 Q3	$16K	Hold	250	–	–	0.01%	221
2020 Q2	$19K	Sell	250 -586	-70%	-$44.9K	0.02%	188
2020 Q1	$62K	Buy	836 +500	+149%	+$34.5K	0.06%	128
2019 Q4	$22K	Buy	336 +86	+34%	+$5.6K	0.01%	233
2019 Q3	$16K	Hold	250	–	–	0.01%	233
2019 Q2	$17K	Hold	250	–	–	0.01%	222
2019 Q1	$16K	Hold	250	–	–	0.01%	243
2018 Q4	$16K	Hold	250	–	–	0.01%	247
2018 Q3	$19K	Hold	250	–	–	0.01%	255
2018 Q2	$18K	Hold	250	–	–	0.01%	235
2018 Q1	$19K	Hold	250	–	–	0.01%	235
2017 Q4	$18K	Hold	250	–	–	0.01%	251
2017 Q3	$20K	Sell	250 -50	-17%	-$3.82K	0.01%	239
2017 Q2	$21K	Sell	300 -100	-25%	-$6.65K	0.01%	263
2017 Q1	$27K	Hold	400	–	–	0.01%	216
2016 Q4	$29K	Hold	400	–	–	0.02%	239
2016 Q3	$32K	Buy	400 +100	+33%	+$8.12K	0.02%	239
2016 Q2	$25K	Hold	300	–	–	0.01%	249
2016 Q1	$28K	Buy	+300	New	+$27.1K	0.01%	252

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barnett & Company's GILD Position: Q1 2022 in Review

Barnett & Company sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 250 shares — an estimated $18K sold.

Barnett & Company first reported a position in GILD in Q1 2016 and held it in 24 quarters. The position peaked at $62K in Q1 2020. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Barnett & Company reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Barnett & Company sold 250 Gilead Sciences shares in Q1 2022, an estimated $18K.
Barnett & Company first reported a position in Gilead Sciences in Q1 2016 and held it in 24 quarters.
Barnett & Company's Gilead Sciences position peaked at $62K in Q1 2020.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Barnett & Company's 13F filing for Q1 2022, filed 28 Apr 2022.